| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,007 |
888 |
$15K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
778 |
682 |
$7K |
| 20553 |
|
184 |
168 |
$2K |
| 96102 |
|
95 |
78 |
$1K |
| 96132 |
|
31 |
27 |
$510.04 |
| 99215 |
Prolong outpt/office vis |
17 |
15 |
$446.51 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
176 |
160 |
$244.36 |
| 99407 |
|
22 |
19 |
$100.74 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
220 |
192 |
$21.86 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
1,370 |
1,172 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
74 |
63 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
1,370 |
1,171 |
$0.00 |
| G9578 |
Documentation of signed opioid treatment agreement at least once during opioid therapy |
82 |
68 |
$0.00 |
| G9584 |
Patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient interviewed at least once during opioid therapy |
93 |
78 |
$0.00 |
| 4004F |
|
23 |
20 |
$0.00 |
| G9577 |
Patients prescribed opiates for longer than six weeks |
82 |
68 |
$0.00 |
| G9583 |
Patients prescribed opiates for longer than six weeks |
82 |
68 |
$0.00 |
| 1036F |
|
81 |
66 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
18 |
16 |
$0.00 |